Purpura fulminans.
D000671:Amputation, Surgical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001772:Blood Cell Count; D001791:Blood Platelet Disorders / Q000139:chemically induced; D001792:Blood Platelets; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D005734:Gangrene / Q000209:etiology / Q000601:surgery; D006454:Hemoglobins; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008297:Male; D008457:Measles / Q000150:complications; D009336:Necrosis / Q000209:etiology; D011693:Purpura / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000601:surgery / Q000628:therapy; D012156:Reticulocytes; D016038:Skin Transplantation; D013290:Streptococcal Infections / Q000150:complications; D014069:Tonsillitis / Q000150:complications
D000900:Anti-Bacterial Agents; D003911:Dextrans; D006454:Hemoglobins; D006493:Heparin